iSAM Funds UK Ltd Makes New $1.47 Million Investment in Marsh & McLennan Companies, Inc. $MRSH

iSAM Funds UK Ltd bought a new stake in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 8,800 shares of the financial services provider’s stock, valued at approximately $1,467,000. Marsh & McLennan Companies accounts for 1.0% of iSAM Funds UK Ltd’s holdings, making the stock its 18th largest position.

A number of other hedge funds have also modified their holdings of the stock. BlackRock Inc. purchased a new stake in shares of Marsh & McLennan Companies during the second quarter worth $6,583,806,000. State Street Corp acquired a new position in Marsh & McLennan Companies in the 4th quarter worth about $4,057,682,000. Capital International Investors purchased a new stake in shares of Marsh & McLennan Companies during the 4th quarter worth about $3,482,557,000. Capital World Investors acquired a new stake in shares of Marsh & McLennan Companies during the 4th quarter valued at about $3,140,284,000. Finally, Wellington Management Group LLP bought a new stake in shares of Marsh & McLennan Companies in the 4th quarter valued at approximately $2,967,927,000. 87.99% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Marsh & McLennan Companies news, insider Martin South sold 7,100 shares of the business’s stock in a transaction on Tuesday, July 28th. The shares were sold at an average price of $189.99, for a total transaction of $1,348,929.00. Following the completion of the transaction, the insider owned 16,632 shares of the company’s stock, valued at $3,159,913.68. The trade was a 29.92% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Lloyd M. Yates sold 12,000 shares of the firm’s stock in a transaction dated Thursday, July 23rd. The shares were sold at an average price of $175.65, for a total value of $2,107,800.00. Following the completion of the sale, the director directly owned 12,001 shares in the company, valued at approximately $2,107,975.65. This represents a 50.00% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 19,813 shares of company stock valued at $3,597,903 in the last quarter. Insiders own 0.38% of the company’s stock.

Marsh & McLennan Companies Stock Performance

MRSH opened at $187.79 on Thursday. The firm has a market cap of $89.62 billion, a price-to-earnings ratio of 22.96, a P/E/G ratio of 2.60 and a beta of 0.58. The company has a current ratio of 1.14, a quick ratio of 1.14 and a debt-to-equity ratio of 1.22. The stock has a 50 day moving average of $184.24. Marsh & McLennan Companies, Inc. has a twelve month low of $156.60 and a twelve month high of $207.82.

Marsh & McLennan Companies (NYSE:MRSH) last released its quarterly earnings results on Tuesday, July 21st. The financial services provider reported $2.96 EPS for the quarter, beating analysts’ consensus estimates of $2.89 by $0.07. Marsh & McLennan Companies had a net margin of 14.24% and a return on equity of 32.67%. The company had revenue of $7.28 billion for the quarter. Marsh & McLennan Companies’s revenue for the quarter was up 6.2% compared to the same quarter last year. As a group, analysts anticipate that Marsh & McLennan Companies, Inc. will post 10.44 earnings per share for the current fiscal year.

Marsh & McLennan Companies Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 14th. Investors of record on Thursday, July 23rd were issued a $0.99 dividend. This is a boost from Marsh & McLennan Companies’s previous quarterly dividend of $0.90. The ex-dividend date was Thursday, July 23rd. This represents a $3.96 annualized dividend and a yield of 2.1%. Marsh & McLennan Companies’s payout ratio is 48.41%.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on MRSH shares. Piper Sandler cut their price objective on shares of Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 26th. Cantor Fitzgerald boosted their target price on shares of Marsh & McLennan Companies from $210.00 to $218.00 and gave the stock an “overweight” rating in a research report on Thursday, July 9th. Weiss Ratings upgraded shares of Marsh & McLennan Companies from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, August 7th. UBS Group lifted their price objective on shares of Marsh & McLennan Companies from $212.00 to $216.00 and gave the company a “buy” rating in a research note on Monday, July 27th. Finally, Morgan Stanley increased their target price on shares of Marsh & McLennan Companies from $180.00 to $200.00 and gave the stock an “equal weight” rating in a research report on Wednesday, August 19th. One research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, eleven have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $203.50.

Marsh & McLennan Companies Profile

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.